Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors.

Jean‐Charles Soria, Michael Millward, Jennifer R. Brown et al.|Journal of Clinical Oncology|2012

Cited by 14